CLINICAL_TRIALS
trial_result
· 2023-12-28
Clinical Trial Update: Study Investigating NTLA-5001 in Subjects With Acute Myeloid Leukemia [Phase 1, Phase 2]
Summary
Phase 1/2 clinical trial of NTLA-5001 in Acute Myeloid Leukemia has been terminated; results posted previously.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Intellia Therapeutics | Conditions: Acute Myeloid Leukemia | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2023-12-28